Effects of combined dopamine and serotonin transporter inhibitors on cocaine self-administration in rhesus monkeys

Journal of Pharmacology and Experimental Therapeutics

Volumn 320, Issue 2, 2007, Pages 757-765

  Howell, Leonard L ^a,b   Carroll, F Ivy ^c   Votaw, John R ^b   Goodman, Mark M ^b   Kimmel, Heather L ^a,b  

^a EMORY UNIVERSITY   (United States)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c RTI INTERNATIONAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3BETA (4 CHLOROPHENYL)TROPANE 2BETA [3 (4' METHYLPHENYL)ISOXAZOL 5 YL]HYDROCHLORIDE; CITALOPRAM; COCAINE; DOPAMINE UPTAKE INHIBITOR; FLUOXETINE; RTI 336; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; COCAINE DEPENDENCE; CONTROLLED STUDY; DOSE RESPONSE; DRUG BLOOD LEVEL; DRUG SELF ADMINISTRATION; FEMALE; MALE; NONHUMAN; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RHESUS MONKEY;

ANIMALS; COCAINE; DOPAMINE PLASMA MEMBRANE TRANSPORT PROTEINS; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; FLUOXETINE; MACACA MULATTA; MALE; SELF ADMINISTRATION; SEROTONIN UPTAKE INHIBITORS; TROPANES;

EID: 33846457359     PISSN: 00223565     EISSN: 15210103     Source Type: Journal    
DOI: 10.1124/jpet.106.108324     Document Type: Article

References (38)

1. Bergman J, Madras BK, Johnson SE, and Spealman RD (1989) Effects of cocaine and related drugs in nonhuman primates. III. Self-administration by squirrel monkeys. J Pharmacol Exp Ther 251:150-155.
2. Carroll ME, Lac ST, Asencio M, and Kragh R (1990) Fluoxetine reduces intravenous cocaine self-administration in rats. Pharmacol Biochem Behav 35:237-244.
3. Cline EJ, Scheffel U, Boja JW, Carroll FI, Katz JL, and Kuhar MJ (1992) Behavioral effects of novel cocaine analogs: a comparison with in vivo receptor binding potency. J Pharmacol Exp Ther 260:1174-1179.
4. Czoty PW, Ginsburg BC, and Howell LL (2002) Serotonergic attenuation of the reinforcing and neurochemical effects of cocaine in squirrel monkeys. J Pharmacol Exp Ther 300:831-837.
5. Ginsburg BC, Kimmel HL, Carroll FI, Goodman MM, and Howell LL (2005) Interaction of cocaine and dopamine transporter inhibitors on behavior and neurochemistry in monkeys. Pharmacol Biochem Behav 80:481-491.
6. Glowa JR and Fantegrossi WE (1997) Effects of dopaminergic drugs on food- and cocaine-maintained responding. IV: continuous cocaine infusions. Drug Alcohol Depend 45:71-79.
7. Glowa JR, Wojnicki FHE, Matecka D, Bacher JJ, Mansbach RS, Balster RL, and Rice KC (1995) Effects of dopamine reuptake inhibitors on food- and cocaine-maintained responding: I. Dependence on unit dose of cocaine. Exp Clin Psychopharmacol 3:219-231.
8. Goodman MM, Kilts CD, Keil R, Shi B, Martarello L, Xing D, Votaw J, Ely TD, Lambert P, Owens MJ, et al. (2000) 18F-Labeled FECNT: a selective radioligand for PET imaging of brain dopamine transporters. 27:1-12.
9. Grabowski J, Rhoades H, Elk R, Schmitz J, Davis C, Creson D, and Kirby K (1995) Fluoxetine is ineffective for treatment of cocaine dependence or concurrent opiate and cocaine dependence: two placebo-controlled double-blind trials. J Clin Psychopharmacol 15:163-174.
10. Grabowski J, Shearer J, Merrill J, and Negus SS (2004) Agonist-like, replacement pharmacotherapy for stimulant abuse and dependence. Addict Behav 29:1439-1464.
11. Heikkila RE and Manzino L (1984) Behavioral properties of GBR12909, GBR13069, GBR13098: specific inhibitors of dopamine uptake. Eur J Pharmacol 103:241-248.
12. Howell LL and Byrd LD (1991) Characterization of the effects of cocaine and GBR 12909, a dopamine uptake inhibitor, on behavior in the squirrel monkey. J Pharmacol Exp Ther 258:178-185.
13. Howell LL and Byrd LD (1995) Serotonergic modulation of the behavioral effects of cocaine in the squirrel monkey. J Pharmacol Exp Ther 275:1551-1559.
14. Howell LL, Czoty PW, Kuhar MJ, and Carroll FI (2000) Comparative behavioral pharmacology of cocaine and the selective dopamine uptake inhibitor RTI-113 in the squirrel monkey. J Pharmacol Exp Ther 292:521-529.
15. Howell LL, Hoffman JM, Votaw JR, Landrum AM, Wilcox KM, and Lindsey KP (2002) Cocaine-induced brain activation determined by positron emission tomography neuroimaging in conscious rhesus monkeys. Psychopharmacology (Berl) 159:154-160.
16. Howell LL and Wilcox KM (2001) The dopamine transporter and cocaine medication development: drug self-administration in nonhuman primates. J Pharmacol Exp Ther 298:1-6.
17. Kimmel HL, Ivy Carroll F, and Kuhar MJ (2001) Locomotor stimulant effects of novel phenyltropanes in the mouse. Drug Alcohol Depend 65:25-36.
18. Kleven MS and Woolverton WL (1993) Effects of three monoamine uptake inhibitors on behavior maintained by cocaine or food presentation in rhesus monkeys. Drug Alcohol Depend 31:149-158.
19. Kuhar MJ (1993) Neurotransmitter transporters as drug targets: recent research with a focus on the dopamine transporter. Pharmacologist 35:28-33.
20. Kuhar MJ, McGirr KM, Hunter RG, Lambert PD, Garrett BE, and Carroll FI (1999) Studies of selected phenyltropanes at monoamine transporters. Drug Alcohol Depend 56:9-15.
21. Lile JA, Wang Z, Woolverton WL, France JE, Gregg TC, Davies HM, and Nader MA (2003) The reinforcing efficacy of psychostimulants in rhesus monkeys: the role of pharmacokinetics and pharmacodynamics. J Pharmacol Exp Ther 307:356-366.
22. Lindsey KP, Wilcox KM, Votaw JR, Goodman MM, Plisson C, Carroll FI, Rice KC, and Howell LL (2004) Effects of dopamine transporter inhibitors on cocaine self-administration in rhesus monkeys: relationship to transporter occupancy determined by positron emission tomography neuroimaging. J Pharmacol Exp Ther 309:959-969.
23. 3H]Cocaine binding sites in caudate-putamen. J Pharmacol Exp Ther 251:131-141.
24. Nader MA, Grant KA, Davies HM, Mach RH, and Childers SR (1997) The reinforcing and discriminative stimulus effects of the novel cocaine analog 2β-propanoyl-3β-(4-tolyl)-tropane in rhesus monkeys. J Pharmacol Exp Ther 280:541-550.
25. Reith MEA, Meisler BE, Sershen H, and Lajtha A (1986) Structural requirements for cocaine congeners to interact with dopamine and serotonin uptake sites in mouse brain and to induce stereotyped behavior. Biochem Pharmacol 35:1123-1129.
26. Ritz MC and Kuhar MJ (1989) Relationship between self-administration of amphetamine and monoamine receptors in brain: comparison with cocaine. J Pharmacol Exp Ther 248:1010-1017.
27. Ritz MC, Lamb RJ, Goldberg SR, and Kuhar MJ (1987) Cocaine receptors on dopamine transporters are related to self-administration of cocaine. Science (Wash DC) 237:1219-1223.
28. Rothman RB, Blough BE, Woolverton WL, Anderson KG, Negus SS, Mello NK, Roth BL, and Baumann MH (2005) Development of a rationally designed, low abuse potential, biogenic amine releaser that suppresses cocaine self-administration. J Pharmacol Exp Ther 313:1361-1369.
29. Spealman RD (1993) Modification of behavioral effects of cocaine by selective serotonin and dopamine uptake inhibitors in squirrel monkeys. Psychopharmacology (Berl) 112:93-99.
30. Spealman RD, Madras BK, and Bergman J (1989) Effects of cocaine and related drugs in nonhuman primates. II. Stimulant effects on scheduled-controlled behavior. J Pharmacol Exp Ther 251:142-149.
31. Villemagne VL, Rothman RB, Yokoi F, Rice KC, Matecka D, Dannals RF, and Wong DF (1999) Doses of GBR12909 that suppress cocaine self-administration in non-human primates substantially occupy dopamine transporters as measured by [11C]WIN35,428 PET scans. Synapse 32:44-50.
32. Volkow ND, Wang GJ, Fischman MW, Foltin RW, Fowler JS, Abumrad NN, Vitkun S, Logan J, Gatley SJ, Pappas N, et al. (1997) Relationship between subjective effects of cocaine and dopamine transporter occupancy. Nature (Lond) 386:827-830.
33. Volkow ND, Wang GJ, Fowler JS, Gatley SJ, Logan J, Ding YS, Dewey SL, Hitzemann R, Gifford AN, and Pappas NR (1999) Blockade of striatal dopamine transporters by intravenous methylphenidate is not sufficient to induce self-reports of "high". J Pharmacol Exp Ther 288:14-20.
34. Votaw JR, Howell LL, Martarello L, Hoffman JM, Kilts CD, Lindsey KP, and Goodman MM (2002) Measurement of dopamine transporter occupancy for multiple injections of cocaine using a single injection of [F-18]FECNT. Synapse 44:203-210.
35. Wee S, Anderson KG, Baumann MH, Rothman RB, Blough BE, and Woolverton WL (2005) Relationship between the serotonergic activity and reinforcing effects of a series of amphetamine analogs. J Pharmacol Exp Ther 313:848-854.
36. Wilcox KM, Kimmel HL, Lindsey KP, Votaw JR, Goodman MM, and Howell LL (2005) In vivo comparison of the reinforcing and dopamine transporter effects of local anesthetics in rhesus monkeys. Synapse 58:220-228.
37. Wilcox KM, Lindsey KP, Votaw JR, Goodman MM, Martarello L, Carroll FI, and Howell LL (2002) Self-administration of cocaine and the cocaine analog RTI-113: relationship to dopamine transporter occupancy determined by PET neuroimaging in rhesus monkeys. Synapse 43:78-85.
38. Woolverton WL and Kleven MS (1988) Multiple dopamine receptors and the behavioral effects of cocaine. NIDA Res Monogr 88:160-184.